)
)
Blau Farmacêutica Investor Relations Material
Latest events
Q3 2024
Blau Farmacêutica
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Blau Farmacêutica S.A
Access all reports
Blau Farmacêutica S.A manufactures and commercializes generic drugs in Brazil, Colombia, Uruguay, Chile, and internationally. The company operates through Institutional and Retail segments. It offers medications covering various therapeutic classes, including immunology, hematology, oncology, nephrology, specialties, and antibiotics. The company is based in Brazil
Key slides for Blau Farmacêutica S.A
Q1 2024
Blau Farmacêutica S.A
Q1 2024
Blau Farmacêutica S.A
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
BLAU3
Country
🇧🇷 Brazil